Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-23-001002
Filing Date
2023-12-27
Accepted
2023-12-27 09:03:07
Documents
2
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1095
2 impldelistreason.txt EX-99.25 1101
  Complete submission text file 0001354457-23-001002.txt   4077
Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

EIN.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE

Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Subject) CIK: 0001445499 (see all company filings)

EIN.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 25-NSE | Act: 34 | File No.: 001-40353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)